Guidelines: NCCN Guidelines (Poland): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 11: Line 11:


'''Access to information:''' [https://www.nccn.org/global/what-we-do/international-adaptations Click here to access], in European editions: Poland (Is necessary to create a login to access the information).
'''Access to information:''' [https://www.nccn.org/global/what-we-do/international-adaptations Click here to access], in European editions: Poland (Is necessary to create a login to access the information).
{{Lobular}}
{{Breast}}
{{Nipple}}
{{Areola}}
{{Ductal}}
{{Esophagus}}
{{Stomach}}
{{Small intestine}}
{{Large intestine}}
{{Rectum}}
{{Anus}}
{{Liver}}
{{Gallbladder}}
{{Bile ducts}}
{{Pancreas}}
{{Colon}}
{{Skin}}
{{Melanoma}}
{{Scalp}}
{{Lips}}
{{Hands}}
{{Feet}}
{{Lung}}
{{Trachea}}
{{Bronchi}}
{{Pleura}}
{{Mediastinum}}
{{Prostate}}
{{Testicles}}
{{Penis}}

Revision as of 02:16, 12 September 2024

Go back to Poland page

Primary purpose: To assist clinicians in determining appropriate and effective avenues of care.

Sponsor, manager or home institution: National Comprehensive Cancer Network (NCCN) and Norodowy Intytut Onkologii.

Type of information: It contains clinical recommendations, treatments, follow up, quality of life, of breast cancer, colon cancer, melanoma, non-small cell lung cancer, prostate cancer and squamous cell skin cancer.

Cancer areas of interest: C50: Breast cancer,C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C30-C39: Lung/chest cancers, C60-C63: Male genitalia cancer. Click here to learn more

Access to information: Click here to access, in European editions: Poland (Is necessary to create a login to access the information).